Cardlytics (NASDAQ:CDLX) Given New $2.50 Price Target at Lake Street Capital

Cardlytics (NASDAQ:CDLXGet Free Report) had its target price lowered by stock analysts at Lake Street Capital from $3.00 to $2.50 in a report issued on Thursday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Lake Street Capital’s price target would indicate a potential upside of 29.20% from the company’s current price.

CDLX has been the topic of several other research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. Evercore ISI dropped their price target on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Cardlytics currently has a consensus rating of “Hold” and an average price target of $5.20.

View Our Latest Report on CDLX

Cardlytics Trading Up 1.8 %

Shares of NASDAQ:CDLX opened at $1.94 on Thursday. The firm has a market capitalization of $100.96 million, a price-to-earnings ratio of -0.32 and a beta of 1.30. The business’s 50 day moving average price is $1.81 and its 200-day moving average price is $2.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a 1 year low of $1.22 and a 1 year high of $10.01.

Insider Transactions at Cardlytics

In related news, CFO Alexis Desieno sold 24,778 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at $479,223.20. This trade represents a 14.95 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now owns 418,637 shares in the company, valued at $1,423,365.80. This trade represents a 10.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 71,938 shares of company stock worth $244,017. 4.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cardlytics

Several large investors have recently added to or reduced their stakes in CDLX. Tallon Kerry Patrick acquired a new position in shares of Cardlytics in the fourth quarter worth $37,000. ProShare Advisors LLC acquired a new stake in Cardlytics in the 4th quarter valued at about $43,000. Virtu Financial LLC purchased a new position in shares of Cardlytics in the 4th quarter valued at about $62,000. SG Americas Securities LLC grew its position in shares of Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after buying an additional 5,392 shares in the last quarter. Finally, Intech Investment Management LLC increased its stake in shares of Cardlytics by 31.3% during the fourth quarter. Intech Investment Management LLC now owns 19,310 shares of the company’s stock worth $72,000 after buying an additional 4,607 shares during the period. 68.10% of the stock is owned by hedge funds and other institutional investors.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

See Also

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.